Three experiments evaluated plasma concentrations of glucose, insulin, IGF-I, and progesterone (P 4 ) in pubertal beef heifers receiving exogenous glucose, insulin, or sometribove zinc. All heifers utilized had no luteal P 4 synthesis but received a controlled internal drug releasing device containing 1.38 g of P 4 to estimate treatment effects on hepatic P 4 degradation. In Exp. 1, 8 nulliparous Angus × Hereford heifers (initial BW = 442 ± 14 kg; initial age = 656 ± 7 d) were randomly assigned to receive, in a crossover design containing 2 periods of 10 h: 1) intravenous (i.v.) insulin infusion (1 μg/kg of BW; INS) or 2) i.v. saline infusion (0.9%; SAL). Treatments were administered via jugular venipuncture in 7 applications (0.15 μg of insulin/kg of BW per application) 45 min apart (from 0 to 270 min). Blood samples were collected immediately before each infusion, as well as at -120, -60, 330, 390, and 450 min relative to the first infusion. Heifers receiving INS had greater (P < 0.01) plasma insulin, reduced (P ≤ 0.04) plasma glucose and IGF-I, but similar (P = 0.62) plasma P 4 concentrations compared with SAL heifers. In Exp. 2, the same heifers were assigned to receive, in a similar experimental design as Exp. 1: 1) i.v. infusion containing insulin (1 μg/kg of BW) and glucose (0.5 g/kg of BW; INS+G) or 2) SAL. Heifers receiving INS+G had greater (P ≤ 0.02) plasma insulin, glucose, and P 4 , but reduced (P = 0.01) plasma IGF-I concentrations compared with SAL heifers. In Exp. 3, the same heifers were assigned to receive, in a crossover design containing 2 periods of 14 d: 1) subcutaneous injection containing 250 mg of sometribove zinc (BST), or 2) SAL. Blood samples were collected 3 h apart (from 0900 to 1800 h) on d 6, 8, and 10 relative to treatment administration (d 1). Heifers receiving BST had greater (P < 0.01) plasma glucose and IGF-I, and similar (P ≤ 0.67) plasma insulin and P 4 concentrations compared with SAL heifers. Results from this series of experiments suggest that concurrent increases in glucose and insulin are required to reduce hepatic catabolism and increase plasma concentrations of P 4 in bovine females.
InTRoduCTIon
Nutrition, more specifically energy intake, is the environmental factor that most influences reproductive function in beef females . Several studies demonstrate that energy intake can be positively associated with hastened attainment of puberty, decreased postpartum interval, and greater pregnancy rates . Moreover, beneficial effects of energy intake on cattle reproduction are regulated, at least partially, by circulating hormones and metabolites such as glucose, insulin, and IGF-I .
As an example, insulin modulates circulating concentrations of progesterone (P 4 ; ), a steroid required for resumption of estrous cycles and establishment and maintenance of pregnancy . More specifically, insulin stimulates luteal P 4 synthesis and alleviates hepatic steroid catabolism . Our research group recently reported that cows in adequate nutritional status receiving intravenous (i.v.) glucose infusion to increase circulating insulin concentrations had greater plasma P 4 concentrations compared with cohorts receiving saline, which was attributed to reduced hepatic P 4 degradation given that cows were ovariectomized and supplemented with exogenous P 4 . However, glucose supplementation also increases circulating concentrations of other hormones associated with reproductive and hepatic functions, including glucose itself and IGF-I .
Therefore, we hypothesized that the insulin-stimulated decrease in hepatic P 4 catabolism may also be dependent on circulating glucose and IGF-I. Based on this rationale, 3 experiments were conducted to evaluate plasma concentrations of glucose, insulin, IGF-I, and P 4 in beef females receiving exogenous insulin, insulin + glucose, or ST.
MATeRIAlS And MeThodS
Animals utilized were cared for in accordance with acceptable practices and experimental protocols reviewed and approved by the Oregon State University, Institutional Animal Care and Use Committee. All experiments were conducted at the Oregon State University -Eastern Oregon Agricultural Research Center (Burns, OR) from January to March 2011. Experiment 1. Eight pubertal, nulliparous Angus x Hereford heifers (initial BW = 452 ± 12 kg; initial age = 656 ± 7 d) were assigned to an estrus synchronization protocol (d -16 to 0 of the study). On d -16 heifers received a 100-µg treatment of GnRH (Cystorelin, Merial Ltd., Duluth, GA) and a controlled internal drug releasing device containing 1.38 g of P 4 (CIDR, Pfizer Animal Health, New York, NY), PGF 2α treatment (25 mg Lutalyse, Pfizer Animal Health) and CIDR removal on d -9, and a second GnRH treatment (100 µg) on d -7. On d 0, heifers received another PGF 2α treatment (25 mg) and a CIDR that remained in heifers throughout Exp. 1 (d 0 to 14). Transrectal ultrasonography examinations were performed immediately and 48 h after the second GnRH (d -7) and PGF 2α (d 0) treatments to verify ovulation and corpus luteum (CL) regression, respectively. All heifers utilized in this experiment responded to the hormonal treatment.
Heifer BW was recorded at the beginning and end of the experiment (d 0 and 14). On d 5, heifers were randomly assigned to receive, in a crossover design containing 2 periods of 10 h each (d 6 and 8): 1) i.v. insulin infusion (1 µg/kg of BW; INS), or 2) i.v. saline infusion (0.9%; SAL). Bovine insulin solution was dissolved into 10 mL of physiological saline immediately prior to infusions and administered via jugular venipuncture in 7 applications (0.15 µg/kg of BW per application) 45 min apart (0, 45, 90, 135, 180, 225 , and 270 min), whereas SAL heifers concurrently received 10 mL of physiological saline. Blood samples were collected immediately before each infusion, as well as at -120, -60, 330, 390, and 450 min relative to the first infusion. All heifers were fasted for 12 h prior to the beginning of each period, and remained fasted during sampling, to prevent any confounding effects between feed intake and infusion treatments on circulating concentrations of P 4 .
Experiment 2. Immediately after the end of Exp.1 (d 14), the same heifers (mean BW = 456 ± 14 kg) received a new CIDR and evaluated via transrectal ultrasonography to confirm the absence of a CL.
Heifer BW was recorded at the beginning and end of the experiment (d 14 and 28). On d 20, heifers were randomly assigned to receive, in a crossover design containing 2 periods of 10 h each (d 20 and 22): 1) i.v. infusion containing insulin (1 µg/kg of BW) and glucose (0.5 g/kg of BW; INS+G), or 2) i.v. saline infusion (0.9%; SAL). Glucose and bovine insulin solution were dissolved into 10 mL of physiological saline immediately prior to infusions. Similarly to Exp. 1, infusion was administered via jugular venipuncture in 7 applications (0.07 g/kg and 0.15 µg/kg of BW per application for glucose and insulin, respectively) 45 min apart. Blood samples were collected immediately before each infusion, as well as at -120, -60, 330, 390, and 450 min relative to the first infusion. As in Exp. 1, heifers were fasted for 12 h prior to the beginning and during the sampling.
Experiment 3. Immediately after the end of Exp. 2 (d 28), heifers (mean BW = 462 ± 14 kg) received a new CIDR and were evaluated via transrectal ultrasonography to confirm the absence of CL.
Heifer BW was recorded at the beginning and end of the experiment (d 28 and 55). On d 28, heifers were randomly assigned to receive, in a crossover design containing 2 periods of 14 d each (d 28 to 42 and 42 to 56): 1) s.c. injection containing 250 mg sometribove zinc (BST; Posilac, Elanco, Greenfield, IN), or 2) subcutaneous (s.c.) saline injection (0.9%; SAL). Treatments were applied once, at 0800 h, during the first day of each period (d 28 and 42). Heifer also received a new CIDR at the beginning of the second period concurrently with treatment administration (d 42).
Four blood samples were collected, 3 h apart (from 0900 to 1800 h) from heifers on d 33, 35, and 37 (period 1) and 47, 49, and 51 (period 2) of the experiment. Similarly to Exp. 1 and 2, all heifers were fasted for 12 h prior to the beginning and during each collection day.
Diets. During all experiments, all heifers were individually offered (as-fed basis) 12 kg of mixed alfalfa-grass hay, 1.0 kg of ground corn, and 0.5 kg of camelina meal in the morning (0700 h). Heifers also received a complete commercial mineral and vitamin mix and water for ad libitum consumption.
Blood Analysis. All blood samples were harvested for plasma and stored at −80°C until assayed for concentrations of glucose (#G7521; Pointe Scientific, Inc., Canton, MI), insulin (B1009; Endocrine Technologies Inc., Newark, CA), IGF-I (SG100; R&D Systems, Inc., Minneapolis, MN), and P 4 (11-PROHU-E01; Alpco Diagnostics, Salem, NH).
Statistical Analysis. All data were analyzed using the PROC MIXED procedure (SAS Inst. Inc., Cary, NC) and Satterthwaite approximation to determine the denominator degrees of freedom for the tests of fixed effects. Heifer was considered the experimental unit for all analysis. The model statement used for Exp. 1 and 2 contained the effects of treatment, time, the resultant interaction, in addition to period as independent variable. Data obtained prior to treatment application (-120, -60, and 0 min prior to infusion) were averaged and used as covariate. Heifer was used as random variable. The specified term for the repeated statement was time, and heifer (treatment × period) was included as subject. The covariance structure utilized was autoregressive, which provided the lowest Akaike information criterion and hence the best fit for all variables analyzed. Results are reported as covariately adjusted least square means if the covariate was significant (P ≤ 0.05), and were separated by LSD. The model statement used for Exp. 3 contained effects of treatment, day, time, and all interactions, in addition to period as independent variable. Heifer was used as random variable. The specified term for the repeated statement was time, and heifer (treatment × day × period) was included as subject. The covariance structure utilized was autoregressive, which provided the lowest Akaike information criterion and hence the best fit for all variables analyzed. Results are reported as least square means and separated using LSD. For all analysis, significance was set at P ≤ 0.05 and tendencies were determined if P > 0.05 and ≤ 0.10. Results are reported according to treatment effects if no interactions were significant or according to highest-order interaction detected.
ReSulTS And dISCuSSIon Experiment 1. Heifer BW did not change (P = 0.51; data not shown) during the experimental period, indicating that heifers were in adequate nutritional status. As expected, mean plasma insulin concentration during the experimental period was greater (P < 0.01) for INS compared with SAL (Table 1) .
A treatment × time interaction was detected (P = 0.01) for plasma glucose (Figure 1 ). After the initial infusion, plasma glucose decreased for INS heifers (time effect; P < 0.01) and did not change for SAL heifers (time effect; P = 0.53). Moreover, mean plasma glucose concentration during the experimental period was reduced (P < 0.01; Table 1) for INS compared with SAL heifers. In agreement, also reported that i.v. insulin infusion reduced circulating glucose concentrations in beef cattle, given that insulin directly estimates the uptake of glucose by body tissues .
Mean plasma IGF-I concentration was reduced (P = 0.04) for INS heifers compared with SAL heifers during the experimental period (Table 1 ). The goal of Exp. 1 was to evaluate if insulin administration would increase plasma P 4 concentrations in beef heifers in adequate nutrient balance, by reducing hepatic P 4 catabolism, independently of circulating concentrations of glucose and IGF-I. However, no treatment effects were detected (P = 0.62) for plasma P 4 concentrations (Table 1) . Therefore, insulin itself may not be capable of alleviating hepatic P 4 catabolism and consequently increasing circulating concentrations of this hormone. Accordingly, research studies documenting the role of insulin on hepatic expression of P 4 catabolic enzymes and resultant plasma P 4 concentrations included glucose infusion into the experimental design.
Experiment 2. Similarly to Exp. 1, BW did not change (P = 0.55; data not shown) during the experimental period. As expected by the experimental design, mean plasma glucose and insulin concentrations during the experimental period were greater (P ≤ 0.01) for INS+G compared with SAL heifers (Table 2) .
Similarly to Exp. 1, INS+G heifers had reduced (P = 0.01) mean plasma IGF-I concentrations compared with SAL heifers during the experimental period (Table 2 ). Other researchers reported that cattle receiving i.v infusion of insulin and glucose had similar or greater circulating IGF-I concentrations compared with cohorts receiving saline .
During the experimental period, INS+G heifers had greater (P = 0.02) mean P 4 concentration compared with SAL heifers (Table 2 ). The goal of Exp. 2 was to evaluate if supplemental glucose modulates the effects of insulin infusion on plasma P 4 concentrations by reducing hepatic P 4 catabolism. In fact, we also expected that INS+G heifers would have greater plasma IGF-I, whereas IGF-I also influences hepatic function and could potentially modulate hepatic steroid catabolism . Nevertheless, results from Exp. 2 suggest that i.v. insulin infusion increased plasma P 4 concentrations by reducing hepatic P 4 catabolism only when supplemental glucose is provided. Therefore, results from Exp. 2 combined with those reported by and suggest that circulating glucose modulates the effects of insulin on hepatic steroid catabolism and subsequent circulating P 4 concentrations in bovine females in adequate nutritional status.
Experiment 3. Similarly to Exp. 1 and 2, BW did not change (P = 0.72; data not shown) during the experimental period. As expected, BST heifers had greater (P < 0.01) mean plasma IGF-I concentrations compared with SAL heifers (Table 3 ), given that sometribove zinc has been shown to increase IGF-I synthesis and circulating concentrations in cattle . Heifers receiving BST had greater (P < 0.01) plasma glucose but similar (P = 0.76) plasma insulin concentrations compared with SAL heifers (Table 3 ). In the present study, the increase in plasma glucose concentrations in BST heifers despite similar insulin concentrations can be attributed to decreased insulin sensitivity caused by sometribove zinc administration .
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During the experimental period, INS+G heifers had greater (P = 0.02) mean P 4 concentration compared with SAL heifers (Table 2 ). The goal of Exp. 2 was to evaluate if supplemental glucose modulates the effects of insulin infusion on plasma P 4 concentrations by reducing hepatic P 4 catabolism. In fact, we also expected that INS+G heifers would have greater plasma IGF-I, whereas IGF-I also influences hepatic function and could potentially modulate hepatic steroid catabolism . Nevertheless, results from Exp. 2 suggest that i.v. insulin infusion increased plasma P 4 concentrations by reducing hepatic P 4 catabolism only when supplemental glucose is provided. Therefore, results from Exp. 2 combined with those reported by and suggest that circulating glucose modulates the effects of insulin on hepatic steroid catabolism and subsequent circulating P 4 concentrations in bovine females in adequate nutritional status. Table 2 . Plasma concentrations of glucose, insulin, IGF-I, and progesterone (P 4 ) in beef heifers receiving i.v. infusion containing insulin (1 !g/kg of BW) and glucose (0.5 g/kg of BW; INS+G; n = 8) or saline (0.9%; SAL; n = 8) in Exp. 2 
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The main goal of Exp. 3 was to determine if circulating IGF-I also modulates hepatic P 4 catabolism and consequent P 4 concentrations given that this hormone directly regulates hepatocytes activity . However, mean plasma P 4 concentrations were similar (P = 0.67) between BST and SAL heifers ( Table 3 ), suggesting that hepatic P 4 catabolism in bovine females in adequate nutritional status is not directly regulated by circulating IGF-I.
IMPlICATIonS
Results collectively suggest that the effects of insulin on hepatic P 4 degradation and circulating P 4 concentrations in bovine females in adequate nutritional status are dependent on circulating glucose, but not IGF-I. In addition, results reported herein indicate that nutritional alternatives to increase circulating concentrations of glucose and insulin may benefit reproductive function of females in adequate nutritional status by increasing circulating concentrations of P 4 .
catabolism in bovine females in adequate nutritional status is not directly regulated by circulating IGF-I. 
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